infectious diseases
rapid diagnostic of pneumonia
big market
Vitro Molecular Diagnostics Market
Care Molecular Diagnostics devices market
cost-effective solution
final users
CAP
updated market studies
children
main source of growth
PneumoSIP product line
antibiotic treatments
main objectives
growing resistance
major cause of morbidity
leading cause of death
higher growth rate
feasibility study
significant advances
sanitation
lab technicians
H2020 SME instrument phase
physicians
medicine
largest segment
world
features
future Pn
company
pathogen identification
microfluidics
AIDS
malaria
mortality
cases
age
addition
hospital admissions
development
Point
specifications
customers
excess
hospitalization rates
pediatric deaths
tuberculosis
problem
AlphaSIP
size
Community
CAGR
lives
years